Skip to search formSkip to main contentSkip to account menu

RGH-4405

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1977
1977
The hemodynamic modifications induced by vincamine and by one of its derivatives, apovincaminic acid ethylester (RGH-4405), have… 
1976
1976
Systemic and cerebral haemodynamic effects of ethyl apovincaminate (RGH-4405, Cavinton), a new compound, have been investigated… 
1976
1976
Some cerebrobiochemical effects of a new cerebrovasodilatory agent, ethyl apovincaminate (RGH-4405, Cavinton) have been studied… 
1976
1976
The effect of ethyl apovincaminate (RGH-4405, Cavinton) on the rheoencephalogram and memory functions was studied in 50 patients… 
1976
1976
The effect of ethyl apovincaminate (RGH-4405, Cavinton) on the cerebral and systemic circulations has been studied in detail in… 
1976
1976
Effects of 1, 2 and 4 mg/kg i.v. doses of ethyl apovincaminate (RGH-4405, Cavinton) on cerebral blood flow, determined in the… 
1976
1976
1976
Absorption, tissue distribution and excretion of tritium labelled ethyl apovincaminate (RGH-4405, Cavinton) were studied. Both… 
1976
1976
Side effects of ethyl apovincaminate (RGH-4405, Cavinton), a cerebral vasodilatory agent, on the central nervous system were… 
1976
1976
Ethyl apovincaminate (RGH-4405, Cavinton) is well metabolized in rat, and only a small fraction of the original compound is…